Cargando…
Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia
BACKGROUND: Endocrinopathies and metabolic complications are common in beta thalassemia major patients receiving blood transfusions. Chelation therapy has a role in preventing or delaying such complications. However, patients may face difficulties adhering to chelation therapy for several reasons. A...
Autores principales: | Habbash, Fatema, Al-Bati, Wegdan, Al-Hashim, Howra, Aldossari, Maryam, Alali, Ahmed, Alalyani, Khalid, Al-Ebrahim, Zainab, Hamed, Nouf, Eraqe, Samma, Binayfan, Ziyad, Al Marri, Azzam, Aljaber, Thamer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741829/ https://www.ncbi.nlm.nih.gov/pubmed/36514312 http://dx.doi.org/10.2147/JBM.S386594 |
Ejemplares similares
-
Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA
por: Alsalman, Mortadah H., et al.
Publicado: (2022) -
Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022) -
Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009) -
Telemedicine in non-communicable chronic diseases care during the COVID-19 pandemic: exploring patients' perspectives
por: Habbash, Fatema, et al.
Publicado: (2023) -
Beliefs about chelation among thalassemia patients
por: Trachtenberg, Felicia L, et al.
Publicado: (2012)